132 related articles for article (PubMed ID: 15544554)
1. Structure-activity relationships of histamine H1-receptor agonists.
Pertz HH; Elz S; Schunack W
Mini Rev Med Chem; 2004 Nov; 4(9):935-40. PubMed ID: 15544554
[TBL] [Abstract][Full Text] [Related]
2. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
3. Histaprodifen, methylhistaprodifen, and dimethylhistaprodifen are potent H1-receptor agonists in the pithed and in the anaesthetized rat.
Malinowska B; Piszcz J; Schlicker E; Kramer K; Elz S; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):11-6. PubMed ID: 9933144
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of specific H1-receptor agonists histaprodifen and its Nalpha-substituted analogues on bovine aortic H1-receptors.
Carman-Krzan M; Bavec A; Zorko M; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):538-46. PubMed ID: 12669185
[TBL] [Abstract][Full Text] [Related]
5. Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists.
Elz S; Kramer K; Pertz HH; Detert H; ter Laak AM; Kühne R; Schunack W
J Med Chem; 2000 Mar; 43(6):1071-84. PubMed ID: 10737740
[TBL] [Abstract][Full Text] [Related]
6. Ring-substituted histaprodifen analogues as partial agonists for histamine H(1) receptors: synthesis and structure-activity relationships.
Elz S; Kramer K; Leschke C; Schunack W
Eur J Med Chem; 2000 Jan; 35(1):41-52. PubMed ID: 10733602
[TBL] [Abstract][Full Text] [Related]
7. Contractile properties of various histaprodifen derivatives in guinea pig isolated ileum and trachea.
Christophe B; Carlier B; Schunack W; Chatelain P; Peck M; Massingham R
Pharmacology; 2007; 79(2):104-13. PubMed ID: 17164592
[TBL] [Abstract][Full Text] [Related]
8. Novel histaprodifen analogues as potent histamine H1-receptor agonists in the pithed and in the anaesthetized rat.
Schlicker E; Kozłowska H; Kwolek G; Malinowska B; Kramer K; Pertz HH; Elz S; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):14-20. PubMed ID: 11485033
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and histamine H1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues.
Leschke C; Elz S; Garbarg M; Schunack W
J Med Chem; 1995 Apr; 38(8):1287-94. PubMed ID: 7731015
[TBL] [Abstract][Full Text] [Related]
10. Side-chain modified analogues of histaprodifen: asymmetric synthesis and histamine H1-receptor activity.
Patil R; Elz S; Reiser O
Bioorg Med Chem Lett; 2006 Feb; 16(3):672-6. PubMed ID: 16266803
[TBL] [Abstract][Full Text] [Related]
11. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study.
Wittmann HJ; Elz S; Seifert R; Straber A
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):287-99. PubMed ID: 21800095
[TBL] [Abstract][Full Text] [Related]
12. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine.
De Esch IJ; Vollinga RC; Goubitz K; Schenk H; Appelberg U; Hacksell U; Lemstra S; Zuiderveld OP; Hoffmann M; Leurs R; Menge WM; Timmerman H
J Med Chem; 1999 Apr; 42(7):1115-22. PubMed ID: 10197956
[TBL] [Abstract][Full Text] [Related]
15. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
[TBL] [Abstract][Full Text] [Related]
16. New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine containing a heteroarylphenyl partial structure.
Krause M; Rouleau A; Stark H; Luger P; Garbarg M; Schwartz JC; Schunack W
Arch Pharm (Weinheim); 1996 Apr; 329(4):209-15. PubMed ID: 8669985
[TBL] [Abstract][Full Text] [Related]
17. N alpha-alkylated derivatives of 2-phenylhistamines: synthesis and in vitro activity of potent histamine H1-receptor agonists.
Kramer K; Elz S; Pertz HH; Schunack W
Bioorg Med Chem Lett; 1998 Sep; 8(18):2583-8. PubMed ID: 9873585
[TBL] [Abstract][Full Text] [Related]
18. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
[TBL] [Abstract][Full Text] [Related]
20. Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.
Ishikawa M; Shinei R; Yokoyama F; Yamauchi M; Oyama M; Okuma K; Nagayama T; Kato K; Kakui N; Sato Y
J Med Chem; 2010 May; 53(9):3840-4. PubMed ID: 20384344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
